Description: This session from the 2003 Washington D.C. Spring Meeting discusses an overview of the development of the 2001 CSO Mortality Table, how the 2001 CSO affects term and whole life products, the tax issues that will arise from adopting the new table and any unresolved issues. From the Record of the Society of Actuaries, Volume 29, No. 1, Session 81PD.

Description: In session 8OF of the Montreal Spring Meeting panelists compare the reserving methods used by Canadian life and health insurers. From the Record of the Society of Actuaries, Vol. 23, No. 2.

Description: There will be no easy resolution to the current trade friction between the U.S. and China. If anything, the motivations for increasing protectionism are set to intensify. What are these motivations? Where is this trade war headed? And what impact could this have on economies and financial markets?

Description: The presenters will share information about: -Insights into causes of death through the use of predictive models, based on a reinsured U.S. life portfolio, using logistic regression models to understand three main causes of death: cancer, heart and external causes; -Opioid abuse is a widespread phenomenon with drug-related mortality rates rising steeply in the U.S. over the past two decades. But what does the most recent data tell U.S. about the outlook for Opioid-related mortality?; -'Deaths of despair' have been publicized as a cause for the poor performance of U.S. mortality in recent years. The presenters will be looking at the different causes under this label, their evolution and explore the drivers behind them.

Description: This session 29PD of the Toronto Spring Meeting describes the stochastic modeling framework developed by Canada for valuation and the practical issues encountered in its implementation. An update on developments in the valuation of similar features in the U.S. is also provided to allow a comparison of the approaches being taken in the two countries. From the Record of the Society of Actuaries, Volume 27, No. 2, Session 29PD

Description: In this session, attendees will learn about the state of the developing reinsurance market for Pension Risk Transfer/Group Annuities in the United States. Discover fundamentals of the primary (group annuity) market and evaluate market forces influencing the lack of significant reinsurance volume of the same nature. This will include a compare and contrast to the PRT and PRT reinsurance markets in other regions that have seen material secondary market volume (such as the UK).

Description: Panelists at this session at the SOA 1998 Maui II Spring Meeting present the SOA's research project on Social Security and mortality projection methods, the results and key issues and how it has been applied in the U.S., Mexico and Canada.

Description: 1988 Valuation Actuary Symposium. This session provided input on the June 9, 1988, draft of a Casualty Actuarial Society Statement of Valuation Principles and the the work product of the CAS Committee on Valuation Principles and Techniques. In addition a comparison of Life and Casualty valuations was provided.

Description: FASB has provided broad guidance for application of the targeted improvements in Actuarial Standards Update 2018-12 for U.S GAAP financial reporting. However, the broad guidance provided leads to several interpretation and modeling challenges for life insurance, annuity, disability and LTC products. The presenters focus these challenges and possible methods to address them. Audience participation is encouraged. At the conclusion of the session, attendees will be able to: - Describe the changes made to U.S. GAAP under the targeted improvements - Explain various interpretations of modeling products under the changes to U.S. GAAP

Description: A pension plan uses Actuarial Equivalence to determine a 'fair' adjustment to pension benefits for form and timing of payment. The definition of Actuarial Equivalence is set in the Plan Document which may not have been reviewed for decades. With a wave of recent pension litigation in the U.S., plan sponsors, attorneys and actuaries now pay more attention to how pension plans define Actuarial Equivalence. How does a change in mortality table or interest rate affect the ultimate benefit? What are the requirements under ERISA and pertinent regulations? Are there court cases that have examined this question before? What are the issues behind the recent lawsuits and what can a plan sponsor do now to reduce their legal exposure? What alternative strategies are available for changing or not changing the definition in the plan document?